S. Lindgren et al., LOW-PREVALENCE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN ULCERATIVE-COLITIS PATIENTS WITH LONG-TERM REMISSION, European journal of gastroenterology & hepatology, 7(6), 1995, pp. 563-568
Objectives: In spite of a strong positive association between ulcerati
ve colitis and the presence of perinuclear anti-neutrophil cytoplasmic
antibodies (p-ANCAs), the immunogenetic significance of these antibod
ies remains unclear. We studied patients with quiescent disease to cla
rify whether ANCAs are present even in the absence of inflammation. De
sign: The prevalence of ANCAs was estimated blindly in 137 patients wi
th ulcerative colitis, 128 of whom had quiescent disease with a mean d
uration of complete clinical and biochemical remission of 14 years. Fo
r comparison, we studied sera from 110 patients with Crohn's disease,
27 of whom had a low or intermediate grade of inflammatory activity. T
he mean duration of complete remission in these patients was 8.5 years
. Methods: ANCAs were detected using indirect immunofluorescence and e
nzyme-linked immunosorbent assays (ELISAs). Results: Only 13 (9%) of 1
37 patients with ulcerative colitis had ANCAs (5% had p-ANCAs). Three
patients had previously undergone colectomy. In patients with Crohn's
disease, ANCAs were observed in 17 of 110 patients (15%, 6% had p-ANCA
s). Fifteen of these patients had colonic disease. Conclusion: In pati
ents with ulcerative colitis free from inflammation for prolonged peri
ods of time, ANCAs occurred less frequently than has previously been r
eported. Patients with Crohn's disease had the expected frequency of A
NCA positivity, which for colonic Crohn's disease was comparable to th
at found in patients with ulcerative colitis. These findings suggest t
hat the titre of ANCAs decreases with time in inactive disease and may
be undetectable with conventional assays after several years of compl
ete remission.